JP2019047818A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019047818A5 JP2019047818A5 JP2018233311A JP2018233311A JP2019047818A5 JP 2019047818 A5 JP2019047818 A5 JP 2019047818A5 JP 2018233311 A JP2018233311 A JP 2018233311A JP 2018233311 A JP2018233311 A JP 2018233311A JP 2019047818 A5 JP2019047818 A5 JP 2019047818A5
- Authority
- JP
- Japan
- Prior art keywords
- rodent
- sirpα
- gene
- human
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000283984 Rodentia Species 0.000 claims 62
- 101000863873 Homo sapiens Tyrosine-protein phosphatase non-receptor type substrate 1 Proteins 0.000 claims 56
- 102100029948 Tyrosine-protein phosphatase non-receptor type substrate 1 Human genes 0.000 claims 26
- 210000004027 cell Anatomy 0.000 claims 25
- 108700024394 Exon Proteins 0.000 claims 9
- 238000000034 method Methods 0.000 claims 9
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 230000003834 intracellular effect Effects 0.000 claims 4
- 229940000406 drug candidate Drugs 0.000 claims 3
- 206010057249 Phagocytosis Diseases 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 2
- 230000008782 phagocytosis Effects 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- 230000008685 targeting Effects 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 210000001671 embryonic stem cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361881261P | 2013-09-23 | 2013-09-23 | |
| US61/881,261 | 2013-09-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016544055A Division JP6453893B2 (ja) | 2013-09-23 | 2014-09-23 | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020026122A Division JP6875573B2 (ja) | 2013-09-23 | 2020-02-19 | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019047818A JP2019047818A (ja) | 2019-03-28 |
| JP2019047818A5 true JP2019047818A5 (enExample) | 2020-02-27 |
| JP6665269B2 JP6665269B2 (ja) | 2020-03-13 |
Family
ID=51663510
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016544055A Active JP6453893B2 (ja) | 2013-09-23 | 2014-09-23 | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 |
| JP2018233311A Active JP6665269B2 (ja) | 2013-09-23 | 2018-12-13 | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 |
| JP2020026122A Active JP6875573B2 (ja) | 2013-09-23 | 2020-02-19 | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 |
| JP2021072857A Active JP7149370B2 (ja) | 2013-09-23 | 2021-04-22 | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016544055A Active JP6453893B2 (ja) | 2013-09-23 | 2014-09-23 | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020026122A Active JP6875573B2 (ja) | 2013-09-23 | 2020-02-19 | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 |
| JP2021072857A Active JP7149370B2 (ja) | 2013-09-23 | 2021-04-22 | ヒト化シグナル調節タンパク質遺伝子を有する非ヒト動物 |
Country Status (28)
| Country | Link |
|---|---|
| US (9) | US9193977B2 (enExample) |
| EP (5) | EP3175706B1 (enExample) |
| JP (4) | JP6453893B2 (enExample) |
| KR (2) | KR102370419B1 (enExample) |
| CN (2) | CN108441497B (enExample) |
| AU (3) | AU2014321187B2 (enExample) |
| CA (1) | CA2925564C (enExample) |
| CY (1) | CY1121410T1 (enExample) |
| DK (4) | DK3434101T5 (enExample) |
| ES (4) | ES2710282T3 (enExample) |
| FI (2) | FI3434101T3 (enExample) |
| HR (3) | HRP20251062T1 (enExample) |
| HU (3) | HUE042412T2 (enExample) |
| IL (4) | IL297607B2 (enExample) |
| LT (3) | LT3434101T (enExample) |
| MX (1) | MX368931B (enExample) |
| NZ (1) | NZ717817A (enExample) |
| PH (1) | PH12016500342A1 (enExample) |
| PL (3) | PL3434101T3 (enExample) |
| PT (4) | PT3175706T (enExample) |
| RS (3) | RS58365B1 (enExample) |
| RU (2) | RU2671166C2 (enExample) |
| SG (3) | SG11201601184UA (enExample) |
| SI (3) | SI3175706T1 (enExample) |
| SM (3) | SMT202500280T1 (enExample) |
| TR (1) | TR201901782T4 (enExample) |
| WO (1) | WO2015042557A1 (enExample) |
| ZA (1) | ZA201601138B (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5874881B2 (ja) | 2009-10-06 | 2016-03-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 遺伝子改変されたマウスおよび移植方法 |
| EP2675271B1 (en) | 2011-02-15 | 2018-06-13 | Regeneron Pharmaceuticals, Inc. | Humanized m-csf mice |
| KR102340059B1 (ko) | 2012-09-07 | 2021-12-17 | 예일 유니버시티 | 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법 |
| US9901082B2 (en) | 2012-11-05 | 2018-02-27 | Regeneron Pharmaceuticals, Inc. | Genetically modified non-human animals and methods of use thereof |
| SG11201601184UA (en) * | 2013-09-23 | 2016-03-30 | Regeneron Pharma | Non-human animals having a humanized signal-regulatory protein gene |
| US9155290B2 (en) | 2013-10-15 | 2015-10-13 | Regeneron Pharmaceuticals, Inc. | Humanized IL-15 animals |
| WO2015077071A1 (en) | 2013-11-19 | 2015-05-28 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized b-cell activating factor gene |
| CN106163273B (zh) | 2014-04-08 | 2020-07-24 | 瑞泽恩制药公司 | 具有人源化FC-γ受体的非人动物 |
| NO2785538T3 (enExample) | 2014-05-07 | 2018-08-04 | ||
| KR102821645B1 (ko) | 2014-05-19 | 2025-06-19 | 리제너론 파마슈티칼스 인코포레이티드 | 인간 epo를 발현하는 유전자 변형된 비-인간 동물 |
| US10390522B2 (en) | 2014-06-19 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized programmed cell death 1 gene |
| MX2017006802A (es) | 2014-11-24 | 2018-01-30 | Regeneron Pharma | Animales no humanos que expresan el complejo cd3 humanizado. |
| TR201903891T4 (tr) | 2014-12-05 | 2019-04-22 | Regeneron Pharma | Bir insanlaştırılmış farklılaşma kümesi 47 genine sahip olan insan dışı hayvanlar. |
| HRP20202034T1 (hr) | 2014-12-09 | 2021-02-19 | Regeneron Pharmaceuticals, Inc. | Neljudske životinje s genom za humanizirani diferencijacijski biljeg cd274 |
| CN107896479B (zh) * | 2015-04-13 | 2021-07-13 | 再生元制药公司 | 人源化SIRPα-IL15敲入小鼠及其使用方法 |
| CN104904661B (zh) * | 2015-06-05 | 2018-07-24 | 杭州正因生物技术有限公司 | 一种人源化小鼠 |
| CA2993835A1 (en) | 2015-08-07 | 2017-02-16 | Alexo Therapeutics Inc. | Constructs having a sirp-alpha domain or variant thereof |
| JP6997708B2 (ja) | 2015-11-20 | 2022-02-04 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化されたｌｙｍｐｈｏｃｙｔｅ－ａｃｔｉｖａｔｉｏｎ ｇｅｎｅ ３遺伝子を有する非ヒト動物 |
| JP6843872B2 (ja) | 2016-02-04 | 2021-03-17 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 操作されたａｎｇｐｔｌ８遺伝子を有する非ヒト動物 |
| RU2749715C2 (ru) | 2016-02-29 | 2021-06-16 | Регенерон Фармасьютикалз, Инк. | Грызуны, характеризующиеся гуманизированным геном tmprss |
| CN108467873B (zh) | 2017-03-17 | 2020-03-13 | 百奥赛图江苏基因生物技术有限公司 | 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用 |
| WO2018177441A1 (en) * | 2017-03-31 | 2018-10-04 | Beijing Biocytogen Co., Ltd | GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα |
| CN108588126B (zh) | 2017-03-31 | 2020-04-10 | 北京百奥赛图基因生物技术有限公司 | Cd47基因人源化改造动物模型的制备方法及应用 |
| CN109136261B (zh) | 2017-06-19 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化cd28基因改造动物模型的制备方法及应用 |
| WO2018233608A1 (en) * | 2017-06-19 | 2018-12-27 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric cd28 |
| JP2020533957A (ja) | 2017-07-31 | 2020-11-26 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | Ｃｒｉｓｐｒリポーター非ヒト動物およびその使用 |
| EP3585159B1 (en) | 2017-07-31 | 2025-05-14 | Regeneron Pharmaceuticals, Inc. | Method of testing the ability of a crispr/cas9 nuclease to modify a target genomic locus in vivo, by making use of a cas-transgenic mouse or rat which comprises a cas9 expression cassette in its genome |
| KR102544051B1 (ko) * | 2017-09-29 | 2023-06-16 | 리제너론 파마슈티칼스 인코포레이티드 | 인간화된 ttr 유전자좌를 포함하는 비인간 동물 및 사용 방법 |
| JP7361031B2 (ja) | 2017-11-30 | 2023-10-13 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
| EP3592140A1 (en) | 2018-03-19 | 2020-01-15 | Regeneron Pharmaceuticals, Inc. | Transcription modulation in animals using crispr/cas systems |
| CN112105260B (zh) | 2018-03-26 | 2023-04-28 | 瑞泽恩制药公司 | 用于测试治疗剂的人源化啮齿动物 |
| SG11202012338QA (en) | 2018-07-10 | 2021-01-28 | Univ Kobe Nat Univ Corp | ANTI-SIRPa ANTIBODY |
| SMT202400300T1 (it) | 2018-07-16 | 2024-09-16 | Regeneron Pharma | Modelli di roditori della sindrome ditra e loro utilizzo |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| WO2020160285A1 (en) * | 2019-02-01 | 2020-08-06 | The Board Of Trustees Of The Leland Stanford Junior University | SIRPα EXPRESSION ON T CELLS IS A BIOMARKER FOR FUNCTIONAL T CELLS DURING EXHAUSTION |
| IL286905B2 (en) | 2019-04-04 | 2024-06-01 | Regeneron Pharma | Non-human animals containing the human coagulation factor 12 locus |
| AU2020282791A1 (en) | 2019-05-31 | 2021-12-09 | ALX Oncology Inc. | Methods of treating cancer with SIRP alpha Fc fusion in combination with an immune checkpoint inhibitor |
| AU2020286382A1 (en) | 2019-06-04 | 2021-11-04 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized TTR locus with a beta-slip mutation and methods of use |
| TW202112229A (zh) | 2019-06-07 | 2021-04-01 | 美商雷傑納榮製藥公司 | 包含人化白蛋白基因座之非人的動物 |
| WO2021136537A1 (en) * | 2019-12-31 | 2021-07-08 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα/CD47 |
| AU2021212668A1 (en) | 2020-01-28 | 2022-08-18 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized PNPLA3 locus and methods of use |
| US20230172170A1 (en) | 2020-04-21 | 2023-06-08 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized cxcl13 gene |
| AU2021409632A1 (en) | 2020-12-21 | 2023-06-29 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra gene |
| US12098214B2 (en) | 2021-05-13 | 2024-09-24 | ALX Oncology Inc. | Combination therapies for treating cancer |
| US20250143272A1 (en) * | 2022-01-25 | 2025-05-08 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Genetically modified non-human animal with human or chimeric nkp46 |
| CN119654068A (zh) | 2022-07-19 | 2025-03-18 | 瑞泽恩制药公司 | 转基因动物模型及其模拟人类免疫系统的用途 |
| US20240224964A9 (en) | 2022-09-29 | 2024-07-11 | Regeneron Pharmaceuticals, Inc. | Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes |
| AU2024304358A1 (en) | 2023-06-16 | 2025-11-06 | Regeneron Pharmaceuticals, Inc. | Vectors, genetically modified cells, and genetically modified non-human animals comprising the same |
| US20250255282A1 (en) | 2024-02-08 | 2025-08-14 | Regeneron Pharmaceuticals, Inc. | Vectors, genetically modified cells, and genetically modified non-human animals comprising the same |
| WO2025212991A1 (en) | 2024-04-05 | 2025-10-09 | Regeneron Pharmaceuticals, Inc. | Rodent models of disease |
| WO2025250495A1 (en) | 2024-05-28 | 2025-12-04 | Regeneron Pharmaceuticals, Inc. | Acceleration of human hepatocyte engraftment in humanized liver animals by supplementing paracrine ligands or agonists that activate human liver regeneration signals |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149635A (en) | 1986-09-12 | 1992-09-22 | Abbott Biotech, Inc. | Messenger RNA stabilization in animal cells |
| EE200000147A (et) | 1997-09-12 | 2001-02-15 | Biogen, Incorporated | April - uus kasvuefekte omav valk |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| JP4936899B2 (ja) * | 2003-12-24 | 2012-05-23 | ジー２ インフラメイション ピーティーワイ エルティーディー | ヒトまたはヒト化Ｃ５ａＲをコードするポリヌクレオチドを含むトランスジェニック非ヒト哺乳動物 |
| AU2005295269B2 (en) | 2004-10-19 | 2010-05-13 | Regeneron Pharmaceuticals, Inc. | Method for generating an animal homozygous for a genetic modification |
| US20060272038A1 (en) | 2005-05-27 | 2006-11-30 | Michael De Vivo | Transgenic Alzheimer's mouse model vectors and uses thereof |
| US20070028316A1 (en) | 2005-06-02 | 2007-02-01 | Xiaoxia Li | Transgenic non-human Act1-deficient mammals and uses thereof |
| EP2388270A3 (en) * | 2007-10-11 | 2012-04-25 | The Hospital For Sick Children | Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| EP2262898B1 (en) | 2008-03-07 | 2018-01-24 | Regeneron Pharmaceuticals, Inc. | Es cell-derived mice from diploid host embryo injection |
| RU2425880C2 (ru) * | 2009-07-30 | 2011-08-10 | Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН | Способ получения трансгенных мышей |
| JP5874881B2 (ja) | 2009-10-06 | 2016-03-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 遺伝子改変されたマウスおよび移植方法 |
| EP2618656B1 (en) * | 2010-09-20 | 2018-06-20 | Yale University, Inc. | HUMAN SIRPalpha TRANSGENIC ANIMALS AND THEIR METHODS OF USE |
| CN104774871A (zh) * | 2011-02-14 | 2015-07-15 | 雷维维科公司 | 用于血管化异种移植物及其衍生物的异种移植的遗传修饰的猪 |
| EP2675271B1 (en) | 2011-02-15 | 2018-06-13 | Regeneron Pharmaceuticals, Inc. | Humanized m-csf mice |
| PL2663575T3 (pl) | 2011-10-28 | 2015-03-31 | Regeneron Pharma | Humanizowane IL-6 i receptor IL-6 |
| PT2770821T (pt) | 2011-10-28 | 2017-12-18 | Regeneron Pharma | Ratinhos de complexo principal de histocompatibilidade principal modificados geneticamente |
| HRP20220616T1 (hr) | 2011-10-28 | 2022-06-24 | Regeneron Pharmaceuticals, Inc. | Genetski modificirani miš koji eksprimira kimerne molekule glavnog kompleksa histokompatibilnosti (mhc) ii |
| US8962913B2 (en) | 2012-06-18 | 2015-02-24 | Regeneron Pharmaceuticals, Inc. | Humanized IL-7 rodents |
| KR102340059B1 (ko) | 2012-09-07 | 2021-12-17 | 예일 유니버시티 | 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법 |
| US9901082B2 (en) | 2012-11-05 | 2018-02-27 | Regeneron Pharmaceuticals, Inc. | Genetically modified non-human animals and methods of use thereof |
| KR102369454B1 (ko) | 2013-02-20 | 2022-03-04 | 리제너론 파아마슈티컬스, 인크. | 사람화된 ｔ-세포 보조-수용체를 발현하는 마우스 |
| CN110192541B (zh) | 2013-02-22 | 2022-02-18 | 瑞泽恩制药公司 | 表达人源化主要组织相容性复合物的小鼠 |
| SG11201601184UA (en) | 2013-09-23 | 2016-03-30 | Regeneron Pharma | Non-human animals having a humanized signal-regulatory protein gene |
| WO2016175285A1 (ja) | 2015-04-30 | 2016-11-03 | 株式会社特殊免疫研究所 | ヒト特定分子およびヒトＦｃγ受容体ファミリーを発現するトランスジェニック非ヒト動物 |
-
2014
- 2014-09-23 SG SG11201601184UA patent/SG11201601184UA/en unknown
- 2014-09-23 PT PT16206491T patent/PT3175706T/pt unknown
- 2014-09-23 SG SG10201902547SA patent/SG10201902547SA/en unknown
- 2014-09-23 HU HUE16206491A patent/HUE042412T2/hu unknown
- 2014-09-23 EP EP16206491.9A patent/EP3175706B1/en active Active
- 2014-09-23 SG SG10201801326PA patent/SG10201801326PA/en unknown
- 2014-09-23 ES ES16206491T patent/ES2710282T3/es active Active
- 2014-09-23 SI SI201431078T patent/SI3175706T1/sl unknown
- 2014-09-23 SM SM20250280T patent/SMT202500280T1/it unknown
- 2014-09-23 FI FIEP18192264.2T patent/FI3434101T3/fi active
- 2014-09-23 HR HRP20251062TT patent/HRP20251062T1/hr unknown
- 2014-09-23 HR HRP20231121TT patent/HRP20231121T1/hr unknown
- 2014-09-23 PL PL18192264.2T patent/PL3434101T3/pl unknown
- 2014-09-23 DK DK18192264.2T patent/DK3434101T5/da active
- 2014-09-23 RS RS20190162A patent/RS58365B1/sr unknown
- 2014-09-23 ES ES18192264T patent/ES2959333T3/es active Active
- 2014-09-23 PT PT181922642T patent/PT3434101T/pt unknown
- 2014-09-23 RU RU2016110462A patent/RU2671166C2/ru active
- 2014-09-23 SM SM20190067T patent/SMT201900067T1/it unknown
- 2014-09-23 LT LTEP18192264.2T patent/LT3434101T/lt unknown
- 2014-09-23 HU HUE23185050A patent/HUE072332T2/hu unknown
- 2014-09-23 NZ NZ717817A patent/NZ717817A/en unknown
- 2014-09-23 EP EP14781783.7A patent/EP2922394B1/en active Active
- 2014-09-23 PL PL16206491T patent/PL3175706T3/pl unknown
- 2014-09-23 CN CN201810267662.3A patent/CN108441497B/zh active Active
- 2014-09-23 KR KR1020167008334A patent/KR102370419B1/ko active Active
- 2014-09-23 SM SM20230287T patent/SMT202300287T1/it unknown
- 2014-09-23 AU AU2014321187A patent/AU2014321187B2/en active Active
- 2014-09-23 MX MX2016003636A patent/MX368931B/es active IP Right Grant
- 2014-09-23 ES ES23185050T patent/ES3037239T3/es active Active
- 2014-09-23 PT PT147817837T patent/PT2922394T/pt unknown
- 2014-09-23 DK DK16206491.9T patent/DK3175706T3/en active
- 2014-09-23 RU RU2018136614A patent/RU2018136614A/ru not_active Application Discontinuation
- 2014-09-23 DK DK14781783.7T patent/DK2922394T3/en active
- 2014-09-23 HU HUE18192264A patent/HUE063376T2/hu unknown
- 2014-09-23 IL IL297607A patent/IL297607B2/en unknown
- 2014-09-23 SI SI201432041T patent/SI3434101T1/sl unknown
- 2014-09-23 PL PL23185050.4T patent/PL4269430T3/pl unknown
- 2014-09-23 RS RS20230816A patent/RS64573B1/sr unknown
- 2014-09-23 CA CA2925564A patent/CA2925564C/en active Active
- 2014-09-23 RS RS20250788A patent/RS67091B1/sr unknown
- 2014-09-23 EP EP25183430.5A patent/EP4635977A2/en active Pending
- 2014-09-23 DK DK23185050.4T patent/DK4269430T3/da active
- 2014-09-23 SI SI201432112T patent/SI4269430T1/sl unknown
- 2014-09-23 CN CN201480051997.1A patent/CN105592695B/zh active Active
- 2014-09-23 EP EP18192264.2A patent/EP3434101B1/en active Active
- 2014-09-23 TR TR2019/01782T patent/TR201901782T4/tr unknown
- 2014-09-23 JP JP2016544055A patent/JP6453893B2/ja active Active
- 2014-09-23 LT LTEP23185050.4T patent/LT4269430T/lt unknown
- 2014-09-23 LT LTEP16206491.9T patent/LT3175706T/lt unknown
- 2014-09-23 PT PT231850504T patent/PT4269430T/pt unknown
- 2014-09-23 WO PCT/US2014/056910 patent/WO2015042557A1/en not_active Ceased
- 2014-09-23 EP EP23185050.4A patent/EP4269430B1/en active Active
- 2014-09-23 US US14/493,745 patent/US9193977B2/en active Active
- 2014-09-23 FI FIEP23185050.4T patent/FI4269430T3/fi active
- 2014-09-23 KR KR1020227006825A patent/KR102407354B1/ko active Active
- 2014-09-23 ES ES14781783.7T patent/ES2624614T3/es active Active
- 2014-10-17 US US14/516,606 patent/US9127292B2/en active Active
-
2015
- 2015-10-14 US US14/882,531 patent/US9462794B2/en active Active
-
2016
- 2016-02-18 IL IL244187A patent/IL244187B/en active IP Right Grant
- 2016-02-18 ZA ZA2016/01138A patent/ZA201601138B/en unknown
- 2016-02-19 PH PH12016500342A patent/PH12016500342A1/en unknown
- 2016-09-13 US US15/263,916 patent/US9700027B2/en active Active
-
2017
- 2017-06-06 US US15/615,298 patent/US9901083B2/en active Active
-
2018
- 2018-01-10 US US15/866,632 patent/US10206379B2/en active Active
- 2018-11-12 IL IL262958A patent/IL262958A/en active IP Right Grant
- 2018-12-13 JP JP2018233311A patent/JP6665269B2/ja active Active
-
2019
- 2019-01-03 US US16/238,589 patent/US10426146B2/en active Active
- 2019-02-05 HR HRP20190227TT patent/HRP20190227T1/hr unknown
- 2019-02-07 CY CY20191100163T patent/CY1121410T1/el unknown
- 2019-08-15 US US16/541,334 patent/US11019810B2/en active Active
-
2020
- 2020-02-19 JP JP2020026122A patent/JP6875573B2/ja active Active
- 2020-11-12 IL IL278679A patent/IL278679B2/en unknown
- 2020-12-08 AU AU2020286187A patent/AU2020286187B2/en active Active
-
2021
- 2021-04-22 JP JP2021072857A patent/JP7149370B2/ja active Active
- 2021-04-27 US US17/241,171 patent/US12161097B2/en active Active
-
2024
- 2024-09-02 AU AU2024216527A patent/AU2024216527A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019047818A5 (enExample) | ||
| Krusche et al. | Desmoglein 2 mutant mice develop cardiac fibrosis and dilation | |
| Banerjee et al. | Targeted ablation of nesprin 1 and nesprin 2 from murine myocardium results in cardiomyopathy, altered nuclear morphology and inhibition of the biomechanical gene response | |
| WO2015042557A4 (en) | Non-human animals having a humanized signal-regulatory protein gene | |
| JP2019022518A5 (enExample) | ||
| JP2018500012A5 (enExample) | ||
| Kim et al. | S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model | |
| JP2017514501A5 (enExample) | ||
| CN113940309B (zh) | 一种慢性萎缩性胃炎病变的模拟方法及小鼠造模鉴定方法 | |
| JP2017500854A (ja) | ポリペプチド、核酸およびその使用 | |
| Wang et al. | Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: an in vivo model to study Tspo transcription | |
| CN102712687A (zh) | 作为补体激活的抑制剂的masp同种型 | |
| Leclère et al. | Otoferlin as a multirole Ca2+ signaling protein: from inner ear synapses to cancer pathways | |
| JP2019506897A5 (enExample) | ||
| JPWO2002039813A1 (ja) | Ｐｄ−１欠損マウスおよびその用途 | |
| JP2021169461A (ja) | 寿命に関する動物モデル並びに寿命を延ばす及び腫瘍化を阻害する関連方法 | |
| CN102176914B (zh) | 用于诊断和治疗癌症的vhz | |
| Sanematsu et al. | Fhod1, an actin‐organizing formin family protein, is dispensable for cardiac development and function in mice | |
| CN106994185A (zh) | Tie2对视网膜及其他组织中静脉血管的保护作用及应用 | |
| Zupkovitz et al. | Phylogenetic analysis and expression profiling of the Klotho gene family in the short-lived African killifish Nothobranchius furzeri | |
| WO2002064731A2 (fr) | Sequences impliquees dans les phenomenes de suppression tumorale reversion tumorale apoptose et/ou resistance aux virus et leur utilisation comme medicaments | |
| JP2023543232A (ja) | ヘッジホッグシグナル伝達経路の活性化のための強力な結合剤 | |
| JP2002504806A (ja) | 糖尿病媒介タンパク質およびその治療的使用 | |
| Meng et al. | Generation and identification of endothelial-specific Hrh2 knockout mice | |
| JP5971966B2 (ja) | Ｔｄｐ−４３の凝集体が蓄積する疾患の発症リスクを予測する方法、診断薬及び治療薬 |